English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Alopecia areata is a relatively common autoimmune condition. It has an unpredictable course and its etiology has not yet been fully elucidated. Its treatment must be individualized, and aims at suppressing the phase of activity of the disease. Thus, many alternatives are available; however, none of them have been curative or preventive so far. We report the cases of two patients, aged 18 and 43 years, diagnosed with alopecia areata, who underwent topical immunotherapy with diphencyprone, and obtained different results. The application procedures, the results obtained and the clinical follow-up are described.

Topical immunotherapy in the treatment of alopecia areata: the importance of the maintenance phase - report of two cases